The directives are considered as a move initiated by the industry to foster correct and standardized studies with stem cells, also in view of patent applications.
China Bio news, October 14, 2013
The directives are considered as a move initiated by the industry to foster correct and standardized studies with stem cells, also in view of patent applications.
China Bio news, October 14, 2013